Dharmacon

Dharmacon, a brand of Horizon Discovery (formerly part of GE Healthcare), is a provider of research tools focused on gene modulation and gene editing. Their products include RNA interference (RNAi) reagents, CRISPR-Cas9 reagents, cDNA clones, and custom services for gene synthesis and cell line engineering. Dharmacon serves researchers in academia, biotechnology, and pharmaceutical industries, supporting studies in functional genomics, drug discovery, and personalized medicine. The brand is known for its expertise in siRNA design and synthesis, as well as its extensive collection of lentiviral reagents for gene knockdown and overexpression. The company's offerings are designed to enable researchers to investigate gene function, identify drug targets, and develop new therapeutics.